Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review

X-linked deafness (DFNX) is estimated to account for up to 2% of cases of hereditary hearing loss and occurs in both syndromic and non-syndromic forms. <i>POU3F4</i> is the gene most commonly associated with X-linked deafness (DFNX2, DFN3) and accounts for about 50% of the cases of X-lin...

Full description

Bibliographic Details
Main Authors: Emanuele Bernardinelli, Florian Huber, Sebastian Roesch, Silvia Dossena
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/11/6/1695
_version_ 1797595973844729856
author Emanuele Bernardinelli
Florian Huber
Sebastian Roesch
Silvia Dossena
author_facet Emanuele Bernardinelli
Florian Huber
Sebastian Roesch
Silvia Dossena
author_sort Emanuele Bernardinelli
collection DOAJ
description X-linked deafness (DFNX) is estimated to account for up to 2% of cases of hereditary hearing loss and occurs in both syndromic and non-syndromic forms. <i>POU3F4</i> is the gene most commonly associated with X-linked deafness (DFNX2, DFN3) and accounts for about 50% of the cases of X-linked non-syndromic hearing loss. This gene codes for a transcription factor of the POU family that plays a major role in the development of the middle and inner ear. The clinical features of POU3F4-related hearing loss include a pathognomonic malformation of the inner ear defined as incomplete partition of the cochlea type 3 (IP-III). Often, a perilymphatic gusher is observed upon stapedectomy during surgery, possibly as a consequence of an incomplete separation of the cochlea from the internal auditory canal. Here we present an overview of the pathogenic gene variants of <i>POU3F4</i> reported in the literature and discuss the associated clinical features, including hearing loss combined with additional phenotypes such as cognitive and motor developmental delays. Research on the transcriptional targets of POU3F4 in the ear and brain is in its early stages and is expected to greatly advance our understanding of the pathophysiology of POU3F4-linked hearing loss.
first_indexed 2024-03-11T02:43:58Z
format Article
id doaj.art-9b3e2f378ef04599936a09fa0e33a881
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-11T02:43:58Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-9b3e2f378ef04599936a09fa0e33a8812023-11-18T09:26:54ZengMDPI AGBiomedicines2227-90592023-06-01116169510.3390/biomedicines11061695Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A ReviewEmanuele Bernardinelli0Florian Huber1Sebastian Roesch2Silvia Dossena3Institute of Pharmacology and Toxicology, Paracelsus Medical University, 5020 Salzburg, AustriaInstitute of Pharmacology and Toxicology, Paracelsus Medical University, 5020 Salzburg, AustriaDepartment of Otorhinolaryngology, Head and Neck Surgery, Paracelsus Medical University, 5020 Salzburg, AustriaInstitute of Pharmacology and Toxicology, Paracelsus Medical University, 5020 Salzburg, AustriaX-linked deafness (DFNX) is estimated to account for up to 2% of cases of hereditary hearing loss and occurs in both syndromic and non-syndromic forms. <i>POU3F4</i> is the gene most commonly associated with X-linked deafness (DFNX2, DFN3) and accounts for about 50% of the cases of X-linked non-syndromic hearing loss. This gene codes for a transcription factor of the POU family that plays a major role in the development of the middle and inner ear. The clinical features of POU3F4-related hearing loss include a pathognomonic malformation of the inner ear defined as incomplete partition of the cochlea type 3 (IP-III). Often, a perilymphatic gusher is observed upon stapedectomy during surgery, possibly as a consequence of an incomplete separation of the cochlea from the internal auditory canal. Here we present an overview of the pathogenic gene variants of <i>POU3F4</i> reported in the literature and discuss the associated clinical features, including hearing loss combined with additional phenotypes such as cognitive and motor developmental delays. Research on the transcriptional targets of POU3F4 in the ear and brain is in its early stages and is expected to greatly advance our understanding of the pathophysiology of POU3F4-linked hearing loss.https://www.mdpi.com/2227-9059/11/6/1695POU3F4X-linked deafnesstranscription factorhearing lossgene variants
spellingShingle Emanuele Bernardinelli
Florian Huber
Sebastian Roesch
Silvia Dossena
Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review
Biomedicines
POU3F4
X-linked deafness
transcription factor
hearing loss
gene variants
title Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review
title_full Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review
title_fullStr Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review
title_full_unstemmed Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review
title_short Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review
title_sort clinical and molecular aspects associated with defects in the transcription factor pou3f4 a review
topic POU3F4
X-linked deafness
transcription factor
hearing loss
gene variants
url https://www.mdpi.com/2227-9059/11/6/1695
work_keys_str_mv AT emanuelebernardinelli clinicalandmolecularaspectsassociatedwithdefectsinthetranscriptionfactorpou3f4areview
AT florianhuber clinicalandmolecularaspectsassociatedwithdefectsinthetranscriptionfactorpou3f4areview
AT sebastianroesch clinicalandmolecularaspectsassociatedwithdefectsinthetranscriptionfactorpou3f4areview
AT silviadossena clinicalandmolecularaspectsassociatedwithdefectsinthetranscriptionfactorpou3f4areview